Clinical Trial

Rhode Island - Statewide Postpartum Hypertension Remote Surveillance

Study acronym: RI-SPHERES
Recruiting
View on ClinicalTrials.gov →
Summary
This is a hybrid type 1 non-inferiority implementation effectiveness trial among postpartum patients with hypertension (N=1536) that will test the hypothesis that RI-SPHERES (a technologically enabled collaborative care model) is non-inferior to a standard self-measured blood pressure program in terms of persistent hypertension at six weeks postpartum and preventive care receipt within one year of delivery.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-02-18; most recent amendment 2025-06-12.
Status change: Not Yet Recruiting → Recruiting 2025-04-28
Trial Details
NCT Number NCT06842875
Lead Sponsor Women and Infants Hospital of Rhode Island
Collaborators: Brown University, Kent Hospital, Rhode Island
Conditions Hypertension in Pregnancy, Postpartum Preeclampsia, Postpartum Complication
Enrollment 1,536 participants
Start Date 2025-04-15
Primary Completion 2029-03-01 (estimated)
Study Completion 2029-03-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-17